Concepedia
Statistics
Publications
134
Citations
11.3K
H-Index
57
Active since
1974
Affiliations
Moffitt Cancer Center(Current)
University of South Florida
National Cancer Institute
National Institutes of Health
Virginia Commonwealth University
Daniel M. Sullivan is an author at Moffitt Cancer Center specializing in medicine, oncology, and pharmacology.
Publications per year
1974–2024
Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma
Adil Daud, Ronald C. DeConti, Stephanie Andrews et al. · Journal of Clinical Oncology · 2008 · 688 citations
Medicine, Biomedical Sciences, Oncology +16
Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.
Lalitha Shankar, John M. Hoffman, S.L. Bacharach et al. · PubMed · 2006 · 679 citations
Medicine, Nuclear Medicine, Oncology +17
Persistent Activation of Stat3 Signaling Induces Survivin Gene Expression and Confers Resistance to Apoptosis in Human Breast Cancer Cells
Tanya Gritsko, Ann H. Williams, James Turkson et al. · Clinical Cancer Research · 2006 · 566 citations · Full text
Life Sciences, Molecular Biology, Oncology +17
First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
Timothy A. Yap, Yan Li, Amita Patnaik et al. · Journal of Clinical Oncology · 2011 · 543 citations
Medicine, Oncology, Pharmacology +17
Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy.
Carol Parr, Daniel M. Sullivan, Anthony M. Paradiso et al. · Proceedings of the National Academy of Sciences · 1994 · 413 citations
Life Sciences, Pharmacology, Pharmacotherapy +13
1–5 of 134